MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


TOP NEWS: Mediclinic annual performance exceeds pre-pandemic levels

ALN

Mediclinic International PLC on Wednesday said its annual profit doubled on the back of increased client activity as the hospital operator managed to exceed pre-pandemic profitability and restored dividend.

The Stellenbosch-based private hospitals operator boosted its pretax profit two-fold to £211 million for the year ended March 31 from £104 million the year before.

Revenue rose 8% to £3.23 billion from £3.00 billion, helping lift adjusted earnings before interest, taxes, depreciation and amortisation to £522 million, up 23% from £426 million.

In 2020, adjusted Ebitda stood at £480 million, while revenue was at £3.08 billion.

Mediclinic reinstated its dividend, paying out 3.00 pence per share, having skipped it the year before.

Headline earnings per share climbed to 19.0p from 9.6p.

‘The group delivered a strong operational and financial performance this year, driven by increased client activity across our care settings. As disruption from the pandemic receded, the fundamental demand for our broad range of healthcare services drove inpatient and day case revenue up 7%, and outpatient revenue up 10% compared with the prior year. Encouragingly, revenue and earnings exceeded pre-pandemic FY20 levels in all three divisions,’ Chief Executive Officer Ronnie van der Merwe said.

Mediclinic expects the positive momentum in revenue growth, margin improvement and earnings to continue in the 2023 financial year, driven by increased client activity supported by expected underlying economic growth in all three regions.

Seasonal trends in patient activity levels, most notably in Switzerland and the Middle East, are expected to return, in the absence of any material new waves of Covid-19.

Improving profitability and strong cash generation are expected to support continued deleveraging.

Switzerland expects to deliver modest revenue growth.

Southern Africa is likely to deliver revenue growth in the mid-single digit percentage range, while the Middle East projects revenue growth in the high-single digit percentage range.

Copyright 2022 Alliance News Limited. All Rights Reserved.